日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mendelian Randomization and Double Machine Learning Modeling Reveal Brain Imaging-Derived Phenotypes as Functional Contributors to 18 Autoimmune Inflammatory Diseases

孟德尔随机化和双重机器学习建模揭示脑成像衍生的表型是18种自身免疫性炎症疾病的功能性贡献因素

Chen, Jinbin; Wang, Xin; Ding, Haifeng; Zheng, Bosheng; Zeng, Keni; Hu, Chuying; Liu, Jiayi; Zhu, Xiao; Yu, Haibing

Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World Study

转化治疗后行根治性切除术治疗肝细胞癌的生存结局、复发模式及其相应的治疗管理:一项真实世界研究

Xiao, Rui; Yang, Zhenyun; Zheng, Zehao; Liu, Na; Yu, Wei; Lin, Qingyang; Chen, Jinbin; Wang, Juncheng; Zhou, Zhongguo; Zhang, Yaojun; Chen, Minshan; Hu, Dandan

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

更正:肿瘤周围肝细胞中的YTHDF2通过CX3CL1介导的CD8+ T细胞募集来介导化疗诱导的抗肿瘤免疫反应。

Yang, Zhenyun; Wang, Xin; Fu, Yizhen; Wu, Weijie; Hu, Zili; Lin, Qingyang; Peng, Wei; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Xu, Li; Zhang, Yaojun; Hou, Jiajie; Chen, Minshan

Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study

肝动脉灌注化疗联合靶向治疗和免疫治疗与全身化疗治疗晚期肝内胆管癌的疗效比较:一项回顾性队列研究

Zheng, Zhikai; Wang, Jiongliang; Wu, Tianqing; He, Minrui; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Xu, Li; Zhang, Yaojun; Chen, Minshan; Zhou, Zhongguo

Dynamic changes of serum α-fetoprotein predict the prognosis of bevacizumab plus immunotherapy in hepatocellular carcinoma

血清甲胎蛋白的动态变化可预测贝伐珠单抗联合免疫疗法治疗肝细胞癌的预后

Yang, Zhenyun; Fu, Yizhen; Wang, Qianyu; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy

PD-1抑制剂增强HAIC-TKI疗法治疗伴门静脉癌栓的肝细胞癌:真实世界生存获益、安全性及亚组特异性疗效

Cao, Fei; Wen, Chunyong; Wang, Yujia; Tan, Hongtong; Hao, Shaohuan; Chen, Jinbin; Chen, Shuanggang; Shen, Lujun; Xie, Lin; Qi, Han; Huang, Tao; Zhang, Yaojun; Huang, Zilin

Machine learning-based prediction models for renal impairment in Chinese adults with hyperuricaemia: risk factor analysis

基于机器学习的中国高尿酸血症成人肾功能损害预测模型:风险因素分析

Wu, Tianchen; Yang, Hui; Chen, Jinbin; Kong, Wenwen

A Machine Learning Approach to Predicting Mortality Risk in Chemotherapy-Treated Lung Cancer: Machine Learning Model Development and Validation

利用机器学习方法预测化疗治疗肺癌患者的死亡风险:机器学习模型开发与验证

Zou, Jianjun; Huang, Jinyi; Lu, Katie; Lin, Ao; Xie, Chen; Zhang, Jinrong; Rao, Boqi; Li, Zhi; Xie, Dongming; Lu, Ling; Luo, Feng; Chen, Jinbin; Yang, Lei; Qiu, Fuman; Zhang, Xin; Deng, Yibin; Lu, Jiachun

Association between combined urinary phthalate metabolites exposure and grip strength among residents in Guangzhou, China

中国广州居民尿液中邻苯二甲酸酯代谢物暴露量与握力之间的关联

Chen, Jinbin; Shi, Jie; Xu, Guojun; Feng, Wenru; Lv, Jiayun; Shi, Tongxing; Jiang, Qinqin

Social Support, Quality of Life, and Financial Toxicity Among Patients with Hepatocellular Carcinoma

肝细胞癌患者的社会支持、生活质量和经济负担

Liu, Shuyue; Xie, Yawen; Li, Tiantian; Huang, Yanxia; Xu, Danting; Cai, Linli; Fu, Yizhen; Chen, Jinbin; Zhang, Yaojun; Huang, Jia; Hu, Zili